Hetero bags 4 million dollar contract from Hard to Treat Diseases

NewsGuard 100/100 Score

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com) Mellow Hope operating subsidiary is in process of finalizing contract details with Hetero Ltd., www.heterodrugs.com one of the largest pharmaceutical manufacturers in India. This contract has been in the works since March 2009, and its finalization promises solid sales boost for Hard to Treat Diseases.

The contract between secures the supply of raw pharmaceutical material for HTDS' Mellow Hope in the range of about 4 million dollars. The contract completion is in final stages, and the shipments are already scheduled. This contract is bound to strengthen present and future sales of the raising pharmaceutical dragon Mellow Hope of Hard to Treat Diseases (HTDS).

In other company news, since September 24, 2009, when Chinese State Food and Drug Administration (SFDA; http://eng.sfda.gov.cn/eng/) granted the H1N1 vaccine licence to Mellow Hope's exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co. Ltd., Mellow Hope received inquiries from many potential buyers around the world. At the present, the most promising deals on the horizon include deals with Southeast Asia and Chile. Mellow Hope is the largest exporter of vaccines in China and the H1N1 vaccine licence gives the company a great advantage over the competition. The company expects to make progress announcements on the H1N1 front shortly.

Besides Mellow Hope, Hard to Treat Diseases (HTDS) is also a parent company with operations in Serbia based Slavica Biochem. This company focuses on the enhancement and modification of existing and approved medications as well as on cancer research. This MindUp cancer research has been delivering groundbreaking results on the international level. The company expects to make an announcement with a Canadian based pharmaceutical company on this shortly.

To receive future updates, via email including quarterly newsletters and company updates which may not be newsworthy however important to the reader and followers of the company please sign up today free at www.minamargroup.com/updates

Source:

Hard to Treat Diseases

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Canada's plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key